Clinical trials for more treatment choices
Nebraska’s Methodist Health System is an active participant in national and international cancer research studies to improve patient outcomes.
These clinical trials offer unique opportunities for you to access new drugs, new approaches to treatment and new combinations of treatments.
In 2017, 15% of screened Methodist Estabrook Cancer Center patients chose to participate in clinical trials.
The national average for participation in clinical trials is three to five percent. At Methodist Estabrook Cancer Center, 15% of screened patients were trial participants in 2017.
What is a clinical trial?
Clinical trials are research studies to learn better ways to prevent, diagnose and treat cancer. Doctors study new treatments first in a research laboratory, then sometimes in animals and then, if the treatment shows promise, it may become a clinical trial offered to patients.
Each trial is targeted at a particular cancer and stage. If your cancer matches a clinical trial's criteria, you may be asked if you would like to participate as part of your treatment. Participation in a clinical trial may give you access to new treatments or medicines which are not yet approved for general use.
Is a clinical trial right for me?
If your stage and type of cancer can be treated with a clinical trial, you may choose to participate. Each case of cancer is unique. The decision to take part in a clinical trial is made as a treatment team: you, your family, your oncologist and other members of your treatment team. Participation is always voluntary, and the trials are strictly supervised.
Clinical trials are offered for all forms of cancer, including:
- Head and neck
Explore the clinical trials currently being offered.